Limits...
Anti-Inflammatory Mechanism of Neural Stem Cell Transplantation in Spinal Cord Injury

View Article: PubMed Central - PubMed

ABSTRACT

Neural stem cell (NSC) transplantation has been proposed to promote functional recovery after spinal cord injury. However, a detailed understanding of the mechanisms of how NSCs exert their therapeutic plasticity is lacking. We transplanted mouse NSCs into the injured spinal cord seven days after SCI, and the Basso Mouse Scale (BMS) score was performed to assess locomotor function. The anti-inflammatory effects of NSC transplantation was analyzed by immunofluorescence staining of neutrophil and macrophages and the detection of mRNA levels of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6) and interleukin-12 (IL-12). Furthermore, bone marrow-derived macrophages (BMDMs) were co-cultured with NSCs and followed by analyzing the mRNA levels of inducible nitric oxide synthase (iNOS), TNF-α, IL-1β, IL-6 and IL-10 with quantitative real-time PCR. The production of TNF-α and IL-1β by BMDMs was examined using the enzyme-linked immunosorbent assay (ELISA). Transplanted NSCs had significantly increased BMS scores (p < 0.05). Histological results showed that the grafted NSCs migrated from the injection site toward the injured area. NSCs transplantation significantly reduced the number of neutrophils and iNOS+/Mac-2+ cells at the epicenter of the injured area (p < 0.05). Meanwhile, mRNA levels of TNF-α, IL-1β, IL-6 and IL-12 in the NSCs transplantation group were significantly decreased compared to the control group. Furthermore, NSCs inhibited the iNOS expression of BMDMs and the release of inflammatory factors by macrophages in vitro (p < 0.05). These results suggest that NSC transplantation could modulate SCI-induced inflammatory responses and enhance neurological function after SCI via reducing M1 macrophage activation and infiltrating neutrophils. Thus, this study provides a new insight into the mechanisms responsible for the anti-inflammatory effect of NSC transplantation after SCI.

No MeSH data available.


Related in: MedlinePlus

Behavioral assessment and functional recovery by transplanted NSCs after SCI. One week post-SCI, NSCs were transplanted into the injured spinal cord, and Basso Mouse Scale (BMS) scores were recorded weekly. The scores were significantly higher in the NSCs group than in the control group from two weeks to six weeks post-transplantation (n = 5 in each time point per group). Data are represented as the mean ± standard error. * p < 0.05.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC5037660&req=5

ijms-17-01380-f003: Behavioral assessment and functional recovery by transplanted NSCs after SCI. One week post-SCI, NSCs were transplanted into the injured spinal cord, and Basso Mouse Scale (BMS) scores were recorded weekly. The scores were significantly higher in the NSCs group than in the control group from two weeks to six weeks post-transplantation (n = 5 in each time point per group). Data are represented as the mean ± standard error. * p < 0.05.

Mentions: Basso Mouse Scale (BMS) scores were performed at Weeks 1, 2, 3, 4, 5 and 6 post-transplantation to evaluate hindlimb locomotor function. As shown in Figure 3, there was no significant difference of the BMS scores between the control group and the NSC transplantation group at Week 1 post-transplantation (p > 0.05; Figure 3). However, BMS scores of the NSC transplantation group were significantly increased compared to the control group from Week 2 to Week 6 post-transplantation (ANVOA, p < 0.05; Figure 3). Therefore, our results showed that grafted NSCs can facilitate motor function recovery following SCI.


Anti-Inflammatory Mechanism of Neural Stem Cell Transplantation in Spinal Cord Injury
Behavioral assessment and functional recovery by transplanted NSCs after SCI. One week post-SCI, NSCs were transplanted into the injured spinal cord, and Basso Mouse Scale (BMS) scores were recorded weekly. The scores were significantly higher in the NSCs group than in the control group from two weeks to six weeks post-transplantation (n = 5 in each time point per group). Data are represented as the mean ± standard error. * p < 0.05.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC5037660&req=5

ijms-17-01380-f003: Behavioral assessment and functional recovery by transplanted NSCs after SCI. One week post-SCI, NSCs were transplanted into the injured spinal cord, and Basso Mouse Scale (BMS) scores were recorded weekly. The scores were significantly higher in the NSCs group than in the control group from two weeks to six weeks post-transplantation (n = 5 in each time point per group). Data are represented as the mean ± standard error. * p < 0.05.
Mentions: Basso Mouse Scale (BMS) scores were performed at Weeks 1, 2, 3, 4, 5 and 6 post-transplantation to evaluate hindlimb locomotor function. As shown in Figure 3, there was no significant difference of the BMS scores between the control group and the NSC transplantation group at Week 1 post-transplantation (p > 0.05; Figure 3). However, BMS scores of the NSC transplantation group were significantly increased compared to the control group from Week 2 to Week 6 post-transplantation (ANVOA, p < 0.05; Figure 3). Therefore, our results showed that grafted NSCs can facilitate motor function recovery following SCI.

View Article: PubMed Central - PubMed

ABSTRACT

Neural stem cell (NSC) transplantation has been proposed to promote functional recovery after spinal cord injury. However, a detailed understanding of the mechanisms of how NSCs exert their therapeutic plasticity is lacking. We transplanted mouse NSCs into the injured spinal cord seven days after SCI, and the Basso Mouse Scale (BMS) score was performed to assess locomotor function. The anti-inflammatory effects of NSC transplantation was analyzed by immunofluorescence staining of neutrophil and macrophages and the detection of mRNA levels of tumor necrosis factor-&alpha; (TNF-&alpha;), interleukin-1&beta; (IL-1&beta;), interleukin-6 (IL-6) and interleukin-12 (IL-12). Furthermore, bone marrow-derived macrophages (BMDMs) were co-cultured with NSCs and followed by analyzing the mRNA levels of inducible nitric oxide synthase (iNOS), TNF-&alpha;, IL-1&beta;, IL-6 and IL-10 with quantitative real-time PCR. The production of TNF-&alpha; and IL-1&beta; by BMDMs was examined using the enzyme-linked immunosorbent assay (ELISA). Transplanted NSCs had significantly increased BMS scores (p &lt; 0.05). Histological results showed that the grafted NSCs migrated from the injection site toward the injured area. NSCs transplantation significantly reduced the number of neutrophils and iNOS+/Mac-2+ cells at the epicenter of the injured area (p &lt; 0.05). Meanwhile, mRNA levels of TNF-&alpha;, IL-1&beta;, IL-6 and IL-12 in the NSCs transplantation group were significantly decreased compared to the control group. Furthermore, NSCs inhibited the iNOS expression of BMDMs and the release of inflammatory factors by macrophages in vitro (p &lt; 0.05). These results suggest that NSC transplantation could modulate SCI-induced inflammatory responses and enhance neurological function after SCI via reducing M1 macrophage activation and infiltrating neutrophils. Thus, this study provides a new insight into the mechanisms responsible for the anti-inflammatory effect of NSC transplantation after SCI.

No MeSH data available.


Related in: MedlinePlus